1. Lee SY, Jung JY, Lee KJ, Lee SH, Kim SJ, Lee EJ, et al. A case of propylthiouracil induced diffuse pulmonary hemorrhage. Tuberc Respir Dis. 2005. 58:78–82.
2. Sun DS, Kim DK, Lee HJ, Lee HY, Kim DJ, Kim ES, et al. A case of antineutrophil cytoplasmic antibody (ANCA) positive, propylthiouracil-induced diffuse alveolar hemorrhage in Graves' disease. J Korean Endocr Soc. 2007. 22:215–219.
3. Park YK, Yun YW, Sung SS, Park US, Park SH, Woo JH, et al. Propylthiouracil-associated p-ANCA positive vasculitis with focal segmental glomerulosclerosis. Korean J Nephrol. 2004. 23:997–1003.
4. Kim JH, Kim HW, Jang EC, Jung WR, Ko SH, Shin YS, et al. A case of ANCA-positive crescentic glomerulonephritis after propylthiouracil treatment in Graves' disease. Korean J Nephrol. 2005. 24:305–312.
5. Dolman KM, Gans RO, Vervaat TJ, Zevenbergen G, Maingay D, Nikkels RE, et al. Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy. Lancet. 1993. 342:651–652.
6. Gunton JE, Stiel J, Caterson RJ, McElduff A. Clinical case seminar: Anti-thyroid drugs and antineutrophil cytoplasmic antibody positive vasculitis. A case report and review of the literature. J Clin Endocrinol Metab. 1999. 84:13–16.
7. Fujieda M, Hattori M, Kurayama H, Koitabashi Y. Members and Coworkers of the Japanese Society for Pediatric Nephrology. Clinical features and outcomes in children with antineutrophil cytoplasmic autoantibody-positive glomerulonephritis associated with propylthiouracil treatment. J Am Soc Nephrol. 2002. 13:437–445.
8. Dhillon SS, Singh D, Doe N, Qadri AM, Ricciardi S, Schwarz MI. Diffuse alveolar hemorrhage and pulmonary capillaritis due to propylthiouracil. Chest. 1999. 116:1485–1488.
9. Jiang X, Khursigara G, Rubin RL. Transformation of lupus-inducing drugs to cytotoxic products by activated neutrophils. Science. 1994. 266:810–813.
10. Harper L, Cockwell P, Savage CO. Case of propylthiouracil-induced ANCA associated small vessel vasculitis. Nephrol Dial Transplant. 1998. 13:455–458.